Announcement: A New Publication from the American Institute of Physics — Bioengineering Today – PR Newswire (press release)

As people are living longer and healthier lives despite disease, disability and injury, today's research promise is tomorrow's hope. Hope that researchers will continue to uncover human genetics and physiology to better understand all the normal and pathological processes that shape our bodies and our minds. Hope that scientists and engineers can use that knowledge to develop new technologies and devices, new drugs or biologicals, or new policies and preventative practices. Hope that medical researchers will help bring about new, precision medicine approaches to treating diseases and improving human health. Hope that new strides in fundamental physics will be translated unto medicine. And hope that all this will lead to a brighter, healthier future for humanity.

"Your hope is our hope -- that as we move into the future, discoveries that touch humanity, helping make better lives, will touch and help you," said Jason Socrates Bardi, AIP News Director and Editor of Bioengineering Today.

Bioengineering Today is written for professional and enthusiastic general audiences. For professional audiences, the journal offers news briefs and long-form reporting on interdisciplinary research in the biomedical research field. For general audiences, the magazine offers news, investigative analysis and useful information that can be applied to daily life. There are also opportunities for more interaction through Bioengineering Today's Facebook page and Twitter account to engage in further discussions about the topics that interest and inspire readers.

Please visit the Bioengineering Today homepage at https://bioengineeringtoday.org to learn more.

ABOUT BIOENGINEERING TODAY Bioengineering Today is a nonprofit journalism venture owned and operated by the scholarly nonprofit publisher AIP Publishing in Melville, New York. AIP Publishing is a wholly-owned subsidiary of the American Institute of Physics (AIP) in College Park, Maryland, a 501(c)(3) nonprofit. See: http://www.aip.org

ABOUT AIP PUBLISHING AIP Publishing is a wholly owned not-for-profit subsidiary of the American Institute of Physics (AIP). AIP Publishing's mission is to support the charitable, scientific and educational purposes of AIP through scholarly publishing activities in the fields of the physical and related sciences on its own behalf and on behalf of our publishing partners to help them proactively advance their missions. https://publishing.aip.org/

AIP Media Relations 301-209-3090 media@aip.org

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/announcement-a-new-publication-from-the-american-institute-of-physics----bioengineering-today-300469854.html

SOURCE AIP Publishing

https://www.aip.org/

See the rest here:
Announcement: A New Publication from the American Institute of Physics -- Bioengineering Today - PR Newswire (press release)

UW student wins coveted grant to develop HIV rapid test – KING5.com

KING 5's Lili Tan reports

LiLi Tan, KING 2:32 AM. PST February 27, 2017

(Photo: Lili Tan, KING)

SEATTLE -- Some University of Washington students are developing a test which could improve the lives of people around the world.

Its a credit card-sized HIV test called the OLA Simple.

Very much looking like a pregnancy test. So there will be lines and you can know the result right away, Nuttada Panpradist said.

The bioengineering Ph.D. student recently won a $50,000 grant from Massachusetts General Hospital. Panpradist says the APF student technology prize for primary healthcare is a coveted grant, and she is the first UW student to win.

This is essentially the first time that we can get our ideas - that we have been scratching on boards for a long, long time - into action, Panpradist said.

OLA Simple is an HIV rapid test that looks for mutations caused by the virus. Searching for biomarkers means patients could undergo testing five days after possible HIV infection rather than having to wait three months like with traditional lab tests. The test also aims to produce results in one hour instead of nine, and to look for drug resistance to anti-retro viral medications.

Panpradist, who hails from outside Bangkok, Thailand, says many people can often go untested because of stigma. She worked in the medical device field before coming to Seattle.

Thats where I started to realize maybe I can be the one to build these technologies to help save lives, she said.

According to the World Health Organizations most recent data, there were 36.7 million people living with HIV in 2015, with 2.1 million infected that year and 1.1 million who died of AIDS-related complications.

In the U.S., one out of every eight people living with the virus are unaware, according to the Centers for Disease Control.

To stop the spread, early detection is crucial, particularly in developing countries.

It has vast implications. There were some pretty shocking numbers and we were very driven to really try to make this work, said Annie Wong, a UW senior on the research team.

Panpradists students feel a shared sense of duty because they know their science could help solve real-life scenarios.

A lot of research that goes on never is translated to the world and helps people, UW junior David McIntyre said. It gives me extra motivation knowing what's going on in those countries and where we can actually provide help.

( 2017 KING)

Read more:
UW student wins coveted grant to develop HIV rapid test - KING5.com

Building a 3D model of ovarian cancer – Institute of Bioengineering – Video


Building a 3D model of ovarian cancer - Institute of Bioengineering
Watch to find out how researchers from Queen Mary University of London are transforming the field of cancer cell research by using bioengineering techniques to grow the first complex 3D human...

By: QMULOfficial

See the article here:
Building a 3D model of ovarian cancer - Institute of Bioengineering - Video

Regenerate, Rebuild, Restore — Bioengineering Contributions to the Changing Paradigm in Medicine – Video


Regenerate, Rebuild, Restore -- Bioengineering Contributions to the Changing Paradigm in Medicine
The future of bioengineering, it seems, may look less like a cyborg and more like a salamander that can grow back a lost body part. UW Professor Buddy Ratner...

By: UWTV

See original here:
Regenerate, Rebuild, Restore -- Bioengineering Contributions to the Changing Paradigm in Medicine - Video

Welcome video to the BioEngineering Graduate Program with the Pete Petit Institute at Georgia Tech – Video


Welcome video to the BioEngineering Graduate Program with the Pete Petit Institute at Georgia Tech
The BioEngineering Graduate Program with the Petit Institute for Bioengineering and Bioscience at Georgia Tech is ranked #2 in the nation by US News and Worl...

By: Pete Petit

Read more here:
Welcome video to the BioEngineering Graduate Program with the Pete Petit Institute at Georgia Tech - Video

Glutamic Acid Market 2020 Size by Product Portfolio, Demand in Retail Partners, Industry Growth Trends, Total Consumption, Competitive Landscape &…

Global Glutamic Acid market covers a detailed analysis of the market appearances, segmentation, size and progress, market shares, provincial collapses, competitive background, tendencies and several growth strategies for this market. Likewise, the market appearances section of this study describes and defines the complete overview of the Glutamic Acid market. The global market report extent segment offers the market revenues, covering both the momentous growth of the industry and anticipating the upcoming market revenue. In addition, global market separations break down into the key sub-areas which gives a better idea about the market size. The report gives the description of the competitive landscape of the market, market dividends, and an explanation of the foremost companies.

Top Leading Key Players are:

Ningxia EPPEN Bioengineering Stock Co. Ltd, Global Bio-chem Technology Group Company Bachem AG, Iris Biotech GmbH, Kyowa Hakko Bio Co. Ltd, Suzhou Yuanfang Chemical Co. Ltd., Sichuan Tongsheng Amino Acid Co. Ltd, Ajinomoto Co. Inc. ltd., Akzo Nobel N.V. & Evonik Industries AG.

Get Sample Copy of this Report: https://www.adroitmarketresearch.com/contacts/request-sample/265

This search study also includes the present, past and in future Glutamic Acid market strategies, development, share company extent and estimate analysis. Besides this, the possible outcomes and the acquaintance to the improvement of Glutamic Acid market extensively covered in this report.

The Glutamic Acid market report provides inclusive details of the industry with overall competitive landscape and an extensive analysis of SWOT and Porters Five Forces model for the target market. Also, this research report contains complete market segmentation study and all the sub-segments are stated on the basis of growth rate, market size, as well as general attractiveness. The Glutamic Acid market study also offers a thorough information of the market players along with the various strategies they applied to gain market presence. The study contains precise market approximations depending on current market status and future market projections. Likewise, the report supplies business outlining, consumer requirements, contact information as well as product image of essential manufacturers of Glutamic Acid market.

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/glutamic-acid-market

Based on application, the market has been segmented into:

Application SegmentFood additivesAnimal & pet foodPharmaceutical

Glutamic Acid market report studies the current state of the market to analyse the future opportunities and risks. Glutamic Acid market report provides a 360-degree global market state. Potential consumers, market values, and the future scope for the Glutamic Acid market are explained thoroughly to the users in this report. The key players of Glutamic Acid industry, their product portfolio, market share, industry profiles is studied in this report. Adaptation of new ideas and accepting the latest trends are some the reasons for any markets growth. The Global Glutamic Acid market research report gives the deep understanding about the regions where the market is impactful. It also elaborates the big and small vendors working actively all over the globe.

As the industry analysts estimates and extracts the data which are affecting the growth of Glutamic Acid market for the estimated forecast period. It also covers the growth aspects of the market. In addition, it also covers the demand and supply of the Glutamic Acid market research study in the estimated forecast period. Moreover, increased demand from the consumers is also likely to be included to estimate the growth of the market for the estimated forecast period. This section majorly focuses over several developments taking place in the region including substantial development and how are these developments affecting the market. Regional analysis provides a thorough knowledge about the opportunities in business, market status& forecast, possibility of generating revenue, regional market by different end users as well as types and future forecast of upcoming years.

For Any Query on the Glutamic Acid Market: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/265

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

See the article here:
Glutamic Acid Market 2020 Size by Product Portfolio, Demand in Retail Partners, Industry Growth Trends, Total Consumption, Competitive Landscape &...

IIT Guwahati researchers working to develop coronavirus vaccine! – Northeast Now

While the world is facing a major crisis due to the coronavirus (COVID-19) outbreak, the IIT Guwahati researchers are working to develop a vaccine to provide an active acquired immunity to the infectious disease.

A media report said the Indian Institute of Technology (IIT), Guwahati is also making efforts to develop rapid detection and portable diagnostic kits for various viruses and microorganisms.

The group of IIT Guwahati researchers has been led by Prof Sachin Kumar of the Department of Biosciences and Bioengineering.

The report quoted the institute as informing that to find a solution for the diseases, its researchers are exploring possibilities to clone the immunogenic proteins of SARS-CoV-2 to be used as diagnostics and possible vaccine candidates.

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Meanwhile, to prevent the spread of the virus, the institute has also developed the prototype of a Faceshield or mask as per the guideline of the World Health Organisation (WHO).

The team has been led by Dr. Supradip Das of the Department of Design.

Informing about this, the IIT Guwahati on its Twitter handle said: @IITGuwahati has developed the prototype of a Faceshield as per the guideline of the @WHO to be used along with other Personal protective equipment. Faculty has plans to #3Dprint up to 100 pieces. congratulations to Dr. Supradip Das, AP, DoD.

According to the media report, IIT Guwahati has also developed hand-sanitisers as prescribed by the WHO and these are being distributed to everyone on the campus of the institute, including visitors.

The researchers group of the Department of Biosciences and Bioengineering in IIT Guwahati earlier developed recombinant vaccines against Japanese encephalitis and classical swine fever virus.

The research was published in the journal Vaccine and Archives of Virology.

Go here to see the original:
IIT Guwahati researchers working to develop coronavirus vaccine! - Northeast Now